Abstract
<jats:p>The prevalence of AD worldwide is estimated to reach 131 million by 2050. Most disease-modifying treatments and drug trials have failed, due partly to the heterogeneous and complex nature of the disease.</jats:p>
| Original language | English |
|---|---|
| Journal | mSystems |
| DOIs | |
| Publication status | Published - 22 Feb 2022 |
Fingerprint
Dive into the research topics of 'Stratification of the Gut Microbiota Composition Landscape across the Alzheimer's Disease Continuum in a Turkish Cohort'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver